China Food

Mead Johnson announced the latest clinical results of Amgen LGG, localized operation and special distribution market

With the increasing incidence rate of milk protein allergy in children in China in recent years, the nutritional management of milk protein allergy has also become a topic of great concern to pediatric medical experts and parents.

Yesterday, xiaoshidai learned from industry channels that Mead Johnson China business group disclosed the latest research results released by its amminjian deep hydrolyzed casein LGG formula at the “2022 Mead Johnson scientific nutrition International Summit Forum”, which pointed out that “the deep hydrolyzed casein formula with LGG can help children establish oral tolerance by up to 80% in one year, and can effectively reduce the risk of long-term allergy”. The forum also invited academic authorities and pediatricians from the United States, Europe and domestic top research institutions to discuss how to promote the upgrading of the management model of diagnosis and treatment of milk protein allergy in children.

This is the first large-scale academic conference held by authoritative experts and scholars at home and abroad since the operation of the new meizan model. It is reported that this year is also the 80th anniversary of an Minjian’s listing. Mead Johnson also disclosed a series of market deployment for the brand in the Chinese market.

Latest research results

In the above forums, including Professor Colin D. Rudolph, editor in chief of Rudolph Pediatrics, a classic American medical textbook, Professor Chen Tongxin, director of Rheumatology and Immunology Department of Shanghai Children’s Medical Center affiliated to Medical College of Shanghai Jiaotong University, Professor Roberto berni canani, director of European food induced disease research laboratory, and Professor Xu Chundi, Department of Pediatrics, Ruijin Hospital Affiliated to Shanghai Jiaotong University, all shared professional views on the management of milk protein allergy.

Professor Colin D. Rudolph, editor in chief of Rudolph Pediatrics, a classic American medical textbook, introduced the diagnosis and management of global milk protein allergy at the forum, and pointed out that the diagnosis and treatment concept of milk protein allergy should be graded according to the severity and individualized management. Children with mild to moderate milk protein allergy can first add LGG deep hydrolyzed casein formula to establish immune tolerance and return to normal diet as soon as possible, These children account for about 90% of the total children with milk protein allergy.

It is worth noting that Professor Roberto berni canani, director of the European food induced disease research laboratory, shared the latest clinical research results at the forum. The clinical study used five commonly used hypoallergenic formulas in the market to study and track children with milk protein allergy for 36 months. The results showed that anminjian deep hydrolyzed casein LGG formula can make children establish milk protein tolerance faster, return to normal diet, and reduce the risk of long-term allergy. Compared with deep hydrolyzed whey protein formula or amino acid formula, the proportion of subjects with one or more allergic symptoms can be reduced by more than 50%.

It is reported that this latest research achievement has recently been published in the world-renowned academic journal Journal of Pediatrics, and has been recognized by the pediatrics community.

Roberto berni canani shared the latest scientific research achievements of deep hydrolyzed casein formula added with LGG

Participating experts said at the forum that the diagnosis and treatment of milk protein allergy has experienced several periods from standardized diagnosis, simple avoidance of allergens to actively allowing allergic children to quickly establish immune tolerance. Professor canani’s latest research shows that the deep hydrolyzed casein formula with LGG has improved the incidence of long-term allergic symptoms and brought the treatment of milk protein allergy to a new stage.

It is understood that this is also the first time that the deep hydrolysis formula has been proved to help reduce the incidence of long-term allergic symptoms in children, and provides an important basis for the special formula industry to optimize the low sensitivity formula and better manage children’s milk protein allergy.

Xinmeizanfuli special distribution market

According to the survey data published in the Journal of pediatric allergy and immunology in 2021, the incidence rate of milk protein allergy in China has increased by 2.6 times in the past 20 years, reaching 5.7%. This data also means that on average, 6 out of every 100 babies have different degrees of milk protein allergy, and the incidence rate is at a high level worldwide. “Milk protein is the most common food allergen in Chinese infants aged 0-2 years.” Some pediatric experts pointed out.

Professor chentongxin shares the incidence rate of milk protein allergy in China

The growing demand in the Chinese market has also made special formula related to milk protein allergy management products a hot track. As a special formula brand of Mead Johnson for children with milk protein allergy, the deeply hydrolyzed casein formula added with LGG is also gradually increasing its market penetration.

Xiaoshidai once introduced that since Mead Johnson China became a locally owned, localized management, local service and independent business group last year, new Mead Johnson proposed to give full play to international and domestic resources to serve the Chinese market. The above-mentioned Summit Forum is also the first large-scale academic conference held by authoritative experts and scholars at home and abroad since the localized operation of the new meizan model.

Statistics show that Mead Johnson currently has more than 70 infant formula products in the world, of which more than 20 are special formula products, covering the fields of allergy, digestion, preterm birth and metabolic disorders. Since this year, Mead Johnson has introduced the deeply hydrolyzed formula amminjian LGG and amino acid formula amminsu products over 1 year old into the Chinese market to provide scientific nutritional solutions for babies with milk protein allergy over 1 year old.

It is understood that clinical studies have confirmed that an Minjian can not only quickly alleviate the symptoms of milk protein allergy, but also establish oral tolerance, so that babies with milk protein allergy can quickly get rid of allergy. “Nearly 80% of children who eat amminjian LGG can eat cream cakes and biscuits after effective dietary management, which was unthinkable for the parents of children with milk protein allergy in the past.” The company said.

Mead Johnson Amgen has a history of 80 years

It is understood that after this summit forum, Mead Johnson China plans to hold a series of consumer education activities, such as “minbao birthday party” for babies who successfully get rid of allergies, and invite them to taste the taste of cream cake. At the same time, it will also provide consumers with relevant consultation and lecture activities to help establish the concept of scientific nutritional management of milk protein allergy.

Zhu Dingping, President of Mead Johnson China business group, said that as Mead Johnson China becomes a business group with “local ownership, local management, local service and independent operation”, the company will continue to retain the advantages of century old scientific research inheritance and global R & D network, continue to closely contact and cooperate with Mead Johnson global in scientific and technological R & D, product innovation and other aspects, and combine unique Chinese consumption insight, Continuously transform scientific research achievements into high-quality products and provide diversified high-quality products for local consumers.

Pay attention to “snack generation” (wechat: foodinc) “and reply to” Mead Johnson “to see the wonderful news.

Similar Posts

Leave a Reply

Your email address will not be published.